|
2024
|
Invention
|
Pyrimidinyl tyrosine kinase inhibitors.
The present invention provides compounds and composition... |
|
|
Invention
|
Heterocyclic compounds useful as pdk1 inhibitors.
The present invention provides compounds usefu... |
|
|
Invention
|
Heterocyclic pdk1 inhibitors for use to treat cancer.
Described are methods of use of compounds ... |
|
2023
|
Invention
|
Bruton's tyrosine kinase inhibitors.
The present invention provides compounds useful as inhibito... |
|
|
Invention
|
Pharmaceutical formulations, processes for preparation, and methods of use. The present disclosur... |
|
|
Invention
|
Combinations of pdk1 inhibitors and kinase inhibitors. This disclosure is directed to combination... |
|
|
P/S
|
Pharmaceutical and therapeutic preparations for the treatment of patients with viral-associated c... |
|
2022
|
Invention
|
Combination of car t-cell therapy with btk inhibitors and methods of use thereof. The present dis... |
|
|
Invention
|
Vecabrutinib for the treatment of graft-versus-host disease. The present disclosure relates to me... |
|
|
Invention
|
Pharmaceutical formulations, processes for preparation, and methods of use.
The invention relate... |
|
2020
|
P/S
|
pharmaceutical and therapeutic preparations for the treatment of patients with viral-associated c... |
|
|
Invention
|
Hdac inhibitor solid state forms. The present disclosure relates to various solid-state forms of ... |
|
|
Invention
|
Dosages for hdac treatment with reduced side effects. Described herein are certain dosing schedul... |
|
|
Invention
|
Methods of treating virally associated cancers with histone deacetylase inhibitors. Described her... |
|
2019
|
Invention
|
Epigenetic modifiers for use in cellular immunotherapy. Described herein are methods and composit... |
|
2018
|
Invention
|
Pyrimidinyl tyrosine kinase inhibitors. The present invention provides compounds and compositions... |
|
2017
|
Invention
|
Bruton's tyrosine kinase inhibitors. The present invention provides compounds useful as inhibitor... |
|
|
Invention
|
Hdac inhibitors for use with nk cell based therapies. Provided are methods and compositions for t... |
|
|
Invention
|
Histone deacetylase inhibitors for use in immunotherapy. Provided are methods and compositions fo... |
|
2015
|
Invention
|
Heterocyclic compounds useful as pdk1 inhibitors. The present invention provides compounds useful... |
|
2014
|
Invention
|
Methods of treatment using pyridinonyl pdk1 inhibitors. The present invention provides pyridinony... |
|
2007
|
Invention
|
Pyridinonyl pdk1 inhibitors. The present invention provides pyridinonyl PDK1 inhibitors and metho... |
